During the past decade, National Cancer Center Hospital - Gastrointestinal Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Center Hospital - Gastrointestinal Oncology" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "National Cancer Center Hospital - Gastrointestinal Oncology" are "Colorectal Cancer" (1 trials), "Cutaneous Squamous Cell Carcinoma" (1 trials), "Esophageal Squamous Cell Carcinoma (ESCC)" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "National Cancer Center Hospital - Gastrointestinal Oncology" in a lesser frequency.

Most popular intervention types in "National Cancer Center Hospital - Gastrointestinal Oncology" are "Drug" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Capecitabine" (1 trials), "Cemiplimab" (1 trials), "Cisplatin" (1 trials) and "Fluorouracil (5-FU)" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Cancer Center Hospital - Gastrointestinal Oncology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "National Cancer Center Hospital - Gastrointestinal Oncology". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in National Cancer Center Hospital - Gastrointestinal Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Cancer Center Hospital - Gastrointestinal Oncology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".